
Psychemedics Corporation PMD
Quartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Psychemedics Corporation EV 2011-2026 | PMD
EV Jährlich Psychemedics Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.5 M | 32.2 M | 46.3 M | 36.8 M | 55.7 M | 105 M | 113 M | 145 M | 58.8 M | 87.7 M | 81.7 M | 62.6 M | 47.4 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 145 M | 20.5 M | 68.7 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 113.88 | -0.84 % | $ 34.6 B | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 24.83 | 0.4 % | $ 690 M | ||
|
Danaher Corporation
DHR
|
145 B | $ 191.01 | -0.56 % | $ 136 B | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 15.91 | -3.11 % | $ 481 M | ||
|
Guardant Health
GH
|
15.2 B | $ 93.3 | 4.06 % | $ 11.7 B | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 17.67 | -0.84 % | $ 942 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
DexCom
DXCM
|
28.2 B | $ 63.11 | -0.16 % | $ 24.6 B | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 107.16 | -2.24 % | $ 8.84 B | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 16.09 | -1.29 % | $ 173 M | ||
|
IQVIA Holdings
IQV
|
49.6 B | $ 170.62 | -0.01 % | $ 29.3 B | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 269.17 | -1.93 % | $ 22.4 B | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 78.08 | 2.89 % | $ 5.27 B | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 508.52 | 2.52 % | $ 14.7 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 169.54 | 0.78 % | $ 8.4 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 270.0 | 0.27 % | $ 26.2 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.74 | 1.5 % | $ 439 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 8.06 | 0.5 % | $ 1.03 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.98 | 4.39 % | $ 2.16 B | ||
|
Natera
NTRA
|
5.53 B | $ 209.27 | 2.15 % | $ 20.6 B | ||
|
Biodesix
BDSX
|
142 M | $ 14.53 | -5.4 % | $ 1.88 B | ||
|
OpGen
OPGN
|
10.3 M | - | -16.95 % | $ 1.54 M | ||
|
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.44 | 1.41 % | $ 432 M | ||
|
PerkinElmer
PKI
|
4 B | - | -0.91 % | $ 14.7 B | ||
|
Precipio
PRPO
|
42.5 M | $ 28.5 | 9.7 % | $ 45.7 M | ||
|
Personalis
PSNL
|
229 M | $ 6.17 | -6.23 % | $ 366 M | ||
|
Quotient Limited
QTNT
|
393 M | - | -11.32 % | $ 1.1 M | ||
|
Illumina
ILMN
|
15.3 B | $ 126.44 | -1.02 % | $ 20.1 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
990 K | $ 2.69 | 3.86 % | $ 87.3 K | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.16 | -0.46 % | $ 4.96 M | ||
|
BioNano Genomics
BNGO
|
34.1 M | $ 1.17 | 1.74 % | $ 6.37 M | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 2.0 | 1.27 % | $ 8.85 M |